EPISODE · Nov 10, 2022 · 18 MIN
A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD
from HCPLive Podcasts · host HCPLive.com
Dr. Lally of New England Retina Consultants joins to discuss avacincaptad pegol, a promising injection treatment for GA, and its supporting data from the GATHER trial program. Will the complement C5 inhibitor drug receive FDA approval in 2023? Lally discusses this and more on the latest DocTalk.
NOW PLAYING
A Geographic Atrophy Treatment Breakthrough with David R. Lally, MD
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m